Previous 10 | Next 10 |
Alector (NASDAQ: ALEC) was one of the most electrifying stocks on the market Friday, experiencing a monster 53% pop in midafternoon trading. This was entirely justified, given the company's announcement of an exciting new collaboration deal. Friday morning, Alector and pharmac...
Gainers: Sequential Brands Group (SQBG) +88%.Alector (ALEC) +50%.TAT Technologies (TATT) +43%.Marin Software (MRIN) +41%.Overseas Shipholding (OSG) +35%.Staffing 360 Solutions (STAF) +31%.Bridgeline Digital (BLIN) +31%.IDT (IDT) +21%.Nortech Systems (NSYS) +19%.Ocean Power Technologies (OPTT)...
The stock market continued to power ahead on Friday, closing another strong week. The Nasdaq Composite (NASDAQINDEX: ^IXIC) was on track to set another potential record high, with the index up about a third of a percent as of 11:30 a.m. EDT. A lot of Nasdaq investors focus on th...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips AMC Entertainment (NYSE: AMC ) stock is is taking a beating on Friday after getting hit with a short call from Iceberg Research. Source: rblfmr/Shutterstock.com Iceberg Research is a firm that prides itself o...
Alector, Inc. (NASDAQ: ALEC) has reported a strategic global collaboration to develop and commercialize two clinical stage, potential first in class monoclonal antibodies (AL001 and AL101) to elevate progranulin levels (PGRN). PGRN is key regulator of immune activity in ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Alector (NASDAQ: ALEC ) stock is rocketing higher on Friday after the clinical-stage biotechnology company announced a partnership with GlaxoSmithKline (NYSE: GSK ). Source: Willy Barton / Shutterstock.com ...
Gainers: Alector (ALEC) +69%. Lucira Health (LHDX) +9%. Provention Bio (PRVB) +7%.Losers: Iterum Therapeutics (ITRM) -34%. Arrowhead Pharmaceuticals (ARWR) -26%. Alterity Therapeutics (ATHE) -21%. Citius Pharmaceuticals (CTXR) -20%. TRxADE HEALTH (MEDS) -17%. For fu...
TAT Technologies Ltd. (TATT) +48% on new MRO partnership with Honeywell.Staffing 360 Solutions, Inc. (STAF) +43%.Alector (ALEC) +37%.Overseas Shipholding Group (OSG) +34% on receiving a preliminary non-binding proposal for $3.0 per share.Virgin Galactic Holdings (SPCE) +26%.Allied E...
Alector (ALEC) has added ~39.9% in the pre-market after the company and GlaxoSmithKline (GSK) announced a global collaboration agreement on two clinical-stage, monoclonal antibodies, AL001 and AL101.AL001 and AL101 are designed to increase progranulin ((PGRN)) a compound regulating ...
Alector and GSK to co-develop progranulin-elevating monoclonal antibodies, AL001 and AL101, for a range of neurodegenerative diseases, including frontotemporal dementia, amyotrophic lateral sclerosis, Parkinson’s disease and Alzheimer’s disease Companies will co-co...
News, Short Squeeze, Breakout and More Instantly...
--INVOKE-2 is the first global Phas e 2 trial evaluating the safety and efficacy of a TREM2 agonist, AL002, in slowing disease progression in individuals with early Alzheimer’s disease (AD)-- --Baseline characteristics data for the INVOKE-2 study confirm a representative stud...
SOUTH SAN FRANCISCO, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced presentations related to the Company’s TREM2 and progranulin programs at the upcoming Alzheimer's Associatio...
SOUTH SAN FRANCISCO, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in a corporate presentation at the H.C. Wainwright 5 th Annual Neuro Pers...